Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Oncology
Reference15 articles.
1. Yagi A, Ueda Y, Kuroda M, et al. Epidemiologic and clinical analysis of cervical cancer using data from the population-based osaka cancer registry. Cancer Res. 2019;79:1252–9.
2. The report of the Gynecological Oncology Committee Jpn Society of Obst and Gynecol 2019;71:669–686 http://www.jsog-oj.jp/toc07105.php#. Accessed 11 Dec 2020.
3. Tewari KS, Sill MW, Long HJ 3rd, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370:734–43.
4. Suzuki K, Nagao S, Shibutani T, et al. Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer. Gynecol Oncol. 2019;154:554–7.
5. Sasano T, Mabuchi S, Kuroda H, et al. Predictors of survival in patients with FIGO stage IVB cervical cancer. Int J Gynecol Cancer. 2016;26:528–33.